Phase II Study of IMMU-132 Alone or in Combination With Carboplatin in Patients With Triple-Negative Breast Cancer

Clinical trial NCT02161679 · WITHDRAWN

Trial details

NCT number: NCT02161679
Sponsor: Gilead Sciences
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Triple-negative Breast Cancer

Start date: 2016-08-01
Primary completion: 2016-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.